CVS - CVS Health Corporation
73.20 +0.02 (0.03%)
After hours: 6:27PM EST
| Previous close | 74.99 |
| Open | 75.00 |
| Bid | 73.18 x 1400 |
| Ask | 73.26 x 1800 |
| Day's range | 72.64 - 75.04 |
| 52-week range | 51.72 - 77.03 |
| Volume | 10,817,097 |
| Avg. volume | 6,846,490 |
| Market cap | 95B |
| Beta (3Y monthly) | 0.88 |
| PE ratio (TTM) | 20.61 |
| EPS (TTM) | 3.55 |
| Earnings date | 18 Feb 2020 - 24 Feb 2020 |
| Forward dividend & yield | 2.00 (2.67%) |
| Ex-dividend date | 2019-10-23 |
| 1y target est | 79.74 |
- Zacks
UnitedHealth (UNH) to Buy Diplomat, Expand Pharmacy Services
UnitedHealth (UNH) inks an agreement to acquire Diplomat to expand its in-house pharmacy benefit management business.
- Simply Wall St.
Does CVS Health Corporation's (NYSE:CVS) P/E Ratio Signal A Buying Opportunity?
This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We'll look at...
- Zacks
Why Is CVS Health (CVS) Up 3.8% Since Last Earnings Report?
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Yahoo Finance
20 businesses that died in the 2010s
Yahoo Finance takes a look back at some of the biggest corporate busts of the last decade.
- Bloomberg
Elizabeth Warren Wants to Spoil the Megamerger Party
(Bloomberg Opinion) -- The merger floodgates broke open five years ago, and now U.S. Senator Elizabeth Warren wants to close the hatch. Her proposed bill to substantially restrict big corporate tie-ups is more a presidential campaign statement than viable legislation — and it certainly won’t score her any more points with the Wall Street crowd — but she is calling attention to the maniacal pace of dealmaking in corporate America and the need to modernize antitrust laws that have permitted some recent problematic transactions.More than $7 trillion of takeovers of U.S. companies have been announced since this day in 2014 — 52,694 companies to be exact.(1) That compares with just $4.4 trillion of deals in the previous five-year period. The transactions grew over time as balance sheets flush with cash and income statements desperate for growth created a perfect storm, which more often than not was stoked by pliable regulators. The Walt Disney Co. acquired 21st Century Fox Inc.; Charter Communications Inc. bought Time Warner Cable Inc.; CVS Health Corp. took over Aetna Inc.; Marriott International Inc. merged with Starwood Hotels & Resorts Worldwide Inc.; and T-Mobile US Inc. is trying to buy Sprint Corp. Those are just some of the more recognizable names. Warren, one of the top-polling candidates heading into the Democratic primaries, wants to ban deals in which one company has annual revenue of more than $40 billion, or both businesses generate more than $15 billion in sales, according to a draft of the bill reviewed by Bloomberg News. (A notable exception would be companies facing insolvency.) That could effectively prevent every top airline, insurer, manufacturer, oil producer, retailer, technology platform and other conglomerates — perhaps even Warren Buffett’s M&A vehicle, Berkshire Hathaway Inc. — from making any acquisitions. It would sound the M&A death knell. The idea, however, is unlikely to gain broad support among lawmakers.Even so, it’s hard not to notice the rising drumbeat of politicians concerned about overreach by corporate giants, particularly those in the tech field. Senator Amy Klobuchar, another Democratic presidential candidate, plans to introduce separate antitrust legislation soon, Bloomberg News reported, citing a person familiar with the matter. (Michael Bloomberg, the founder and majority owner of Bloomberg LP, the parent of Bloomberg News and Bloomberg Opinion, is also campaigning for president.)For the Trump administration’s part, the U.S. Justice Department is already investigating whether tech giants — namely Apple Inc., Amazon.com Inc., Facebook Inc. and Google — are using their unchecked power to engage in harmful business practices. But as I wrote in July, if regulators are so concerned about protecting consumers from tech overreach, their glowing endorsement of T-Mobile’s takeover of Sprint is a funny way of showing it; it will shrink the U.S. wireless market from four to three major carriers and remove a company that’s helped to keep customer prices in check.Antitrust regulation under President Donald Trump has at times created questionable optics. Makan Delrahim, the Justice Department’s top antitrust enforcer, seemed to switch his stance on AT&T Inc.’s takeover of Time Warner Inc. as Trump railed against the deal. Time Warner was the parent of CNN, which Trump views as his personal nemesis. (I’ve argued that whatever the case, scrutiny of the megamerger was warranted considering the broad market power it gave to AT&T as media companies without such scale struggle to compete.) By comparison, Disney and Fox, which was controlled by Trump pal Rupert Murdoch, closed their megadeal with few regulatory hiccups. Warren has criticized other giant deals, such as the merger of SunTrust Banks Inc. and BB&T Corp. and the combination of seed makers Bayer AG and Monsanto Co. Given that they aren’t household names, though, most Americans are unfazed by or unaware of such deals, even though they may feel the effects later. Her bill would direct the government to take into account not just whether a merger will lead to higher prices but also what the impact might be on workers, privacy and industry innovation. To justify the cost of buying another large company, dealmakers tend to come up with ambitious estimates of synergies, a euphemism for layoffs. It’s clear that the meaning of “harm” needs to be expanded in the antitrust sense, and laws need to take a more holistic view of the potential consequences of M&A as the lines between industries continue to blur. The Big Tech factor also needs to be weighed, as some deals are being done in part to respond to companies like Amazon that are spreading their tentacles into new areas. On Wednesday, TV-network operators CBS Corp. and Viacom Inc. completed their own merger, a bid to cut costs and create more scale to compete against a new roster of even more powerful media giants: Amazon, Apple, AT&T and Disney. Even then, ViacomCBS Inc., as the merged entity is now called, may not be big enough, and so it may be only a matter of time before it gets swallowed. Warren’s overly broad proposal likely isn’t the answer. But Democrats do seem ready to at least try to rein in a market that’s gotten out of hand. For dealmakers, this may be last call at the M&A party.(1) Data compiled by Bloomberg as of Thursday morning. Excludes terminated deals.To contact the author of this story: Tara Lachapelle at tlachapelle@bloomberg.netTo contact the editor responsible for this story: Daniel Niemi at dniemi1@bloomberg.netThis column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Tara Lachapelle is a Bloomberg Opinion columnist covering the business of entertainment and telecommunications, as well as broader deals. She previously wrote an M&A column for Bloomberg News.For more articles like this, please visit us at bloomberg.com/opinion©2019 Bloomberg L.P.
- Zacks
Molina Healthcare Wins Kentucky Medicaid Managed Care Deal
Molina Healthcare's (MOH) Kentucky Medicaid Managed Care contract win to aid 2020 premium revenues.
- Zacks
Centene (CNC) Divests IlliniCare as Part of Merger Agreement
Centene (CNC) inks a deal to divest IlliniCare to CVS Health to facilitate the pre-announced merger agreement.
- Zacks
CVS Health Set to Acquire Centene's IlliniCare Health Plan
CVS Health's (CVS) latest collaboration with Centene is set to expand its Medicaid and Medicare Advantage presence in Illinois.
- Bloomberg
CVS Gains After Report Activist Starboard Took Small Stake
(Bloomberg) -- Shares of CVS Health Corp. rose after a report that activist investment firm Starboard Value LP had taken a small stake in the drugstore chain and held talks with management.Shares of the company, which runs almost 10,000 drugstores across the U.S., closed up 1.7% Monday after the Wall Street Journal’s report.The Journal described the stake in CVS as small, and said the two firms had held amicable discussions. CVS declined to comment. Representatives for Starboard didn’t immediately respond to requests for comment.CVS, which has a market value of roughly $99.6 billion, would be a big target for Starboard. The New York hedge fund hasn’t shied away from mammoth targets though. Earlier this year, for example, it built a small position in Bristol-Myers Squibb Co. in a failed attempt to block its takeover of Celgene Corp.CVS has been transforming itself into a vertically integrated health-care company, with a pharmacy-benefit management unit and a health insurer, Aetna. It’s also transforming some of its stores into so-called health hubs, where people can get medical services.(Updates with CVS declining to comment in third paragraph)\--With assistance from Scott Deveau.To contact the reporter on this story: Robert Langreth in New York at rlangreth@bloomberg.netTo contact the editors responsible for this story: Drew Armstrong at darmstrong17@bloomberg.net, Timothy Annett, Mark SchoifetFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.
- Yahoo Finance
UPS expects to expand private home drone delivery by 2021
UPS has flown more than 1,000 revenue-generating drone delivery flights on medical campuses as it expands into private home delivery. the vice president of UPS advanced technology group discusses the next steps to make drone delivery mainstream.
- Zacks
3 Healthcare Stocks to Counter Tech Encroachment
Traditional U.S. healthcare companies are resorting to vertical integration to counter the tech threat.
- Simply Wall St.
Should You Be Concerned About CVS Health Corporation's (NYSE:CVS) ROE?
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...
- Zacks
The Extreme Risks of Trading Your Own Retirement Assets - November 15, 2019
From understanding your risk tolerance to maintaining emotional control, achieving your retirement goals takes a much different investing approach than regular stock trading.
- Zacks
3 REITs for Dividend Investors to Buy with Stock Market at New Highs
Here are three highly-ranked REITs we found using our Zacks Stock Screener that dividend investors might want to buy with stock indexes at new highs...
- Zacks
Here's Why You Should Hold on to CVS Health (CVS) For Now
Investors can still hold on to CVS Health (CVS) stock, thanks to its solid prospects.
- Zacks
Walgreens Boots Rallies on KKR's Bid but Market View Mixed
Albeit the market sentiment is bullish on Walgreens Boots' (WBA) potential acquisition deal, many analysts are in doubt about the company's effective approach to get privatized.
- Zacks
CVS Health's New Plans With Aetna May Improve Health Outcomes
CVS Health's (CVS) Health Care Benefits segment develops Medicare program with Aetna.
- Zacks
Want To Retire Early? Learn the Intelligent Investing Secret - November 13, 2019
Accomplishing the financial cushion to retire early is a fantasy for most, but bringing that fantasy to reality is not as difficult as it sounds. If you are willing to make some serious lifestyle adjustments, it can be achievable.
- Zacks
CVS Health's Aetna Prospects Solid, Omnicare Sluggish
CVS Health's (CVS) strong Pharmacy Services segment sales gain traction from growth in specialty services.
- Zacks
The Zacks Analyst Blog Highlights: Mastercard, UnitedHealth, Merck, Qualcomm and CVS Health
The Zacks Analyst Blog Highlights: Mastercard, UnitedHealth, Merck, Qualcomm and CVS Health
- Zacks
Top Analyst Reports for Mastercard, UnitedHealth & Merck
Top Analyst Reports for Mastercard, UnitedHealth & Merck
- Bloomberg
Netflix, Disney Already Won the Streaming Wars: The Year Ahead
(Bloomberg) -- Bloomberg is hosting The Year Ahead Summit in New York, featuring top thinkers in technology, finance and health care, among other industries, for wide-ranging discussions on their vision of what 2020 has in store. Among key speakers were Sheryl Sandberg, chief operating officer of Facebook Inc., who said next year’s presidential election in the U.S. will be a “massive test” for the social networking giant. Other participants included Jonathan Nelson, head of Providence Equity Partners, who said he already knows who will win the so-called streaming wars: Netflix Inc. and Walt Disney Co.For the day’s agenda, see here. Here are the latest comments:Cannabis Firm Is ‘Lobbying Very Hard’ to Get Pot Fully Legalized (4:15 p.m.)It will take five years or more for the U.S. federal government to fully legalize cannabis, said Joe Lusardi, chief executive officer of Curaleaf Holdings Inc., the largest U.S. pot company by market value.“We’re lobbying very hard,” Lusardi said. “The conflict between state and federal law has to be resolved.”He’s more optimistic about other pieces of pro-cannabis legislation, including the SAFE Banking Act, which recently passed the House and would allow banks to do business with legal cannabis companies.Lusardi said regulation is essential to prevent problems like the vaping health crisis that’s sickened more than 2,000 and killed 39 in the U.S. Regulators have said the outbreak appears to be linked to the use of black-market products containing THC, the psychoactive ingredient in marijuana.“Our biggest competitor is the black market, it’s the drug dealer,” he said. “You have to put it in that context to understand why we’re trying to lead a world where cannabis is accepted, regulated and safe.”The Future of DNA Testing Is In Making People Healthier (3:55 p.m.)Today’s consumer DNA tests are mainly a novelty, but in time they will become part of standard health care, Ancestry.com LLC Chief Executive Officer Margo Georgiadis said.Just last month, the DNA testing giant unveiled its own entry into the growing and potentially lucrative field of genetic health screenings, putting it head-to-head with its biggest competitor, 23andMe, Inc.But unlike 23andMe, which has received Food and Drug Administration approval for its tests, Ancestry’s tests must be ordered by a doctor.msg4“We didn’t want to be another lab report provider,” Georgiadis said. “We needed to get people from the lab report to action.”She said the company has focused on providing genetic testing results only for conditions that have treatments available. Ancestry does not, for example, provide genetic testing results for Alzheimer’s disease as some of its competitors do, since there is currently no way to prevent or cure it.“What’s really going to advance this industry is how do we help get people to better health outcomes?” she said. “That’s where we are really adding value and solving problems.”In the future, she said, DNA tests like Ancestry’s may become integrated into a patient’s care, helping them to take preventative steps in order to avoid developing conditions they may be at risk for and lead an overall healthier life.“We can make this really over time standard of care,” she said.Susan Rice Says Trump ‘Squandered the Goodwill’ of U.S. Allies (3:15 p.m.)President Donald Trump’s administration has “squandered the goodwill” of U.S. allies by betraying their trust, even as it cozies up to rivals such as Russia and North Korea, said Susan Rice, former national security adviser to President Barack Obama.America’s ability to bring allies together in global coalitions to tackle challenges from the Ebola outbreak to the Syrian crisis is indispensable, but the Trump administration has effectively abandoned that role, she said.“There is literally not a problem on the globe that we can tackle effectively purely through unilateral U.S. action,” said Rice. “We have elevated and lionized our adversaries and denigrated the men and women of the national security community in this country.”Sarah Jessica Parker Said No to Mass-Market for Her Shoe Collection (2:30 p.m.)Sarah Jessica Parker said she wants to be smart when expanding her shoe business because growth in retail these days is “riddled with fear and risk.” So she’s going to stay cautious.Parker and George Malkemus, a former Manolo Blahnik executive, own and run shoe label SJP Collection. After her starring role as Carrie Bradshaw in “Sex and the City” forever linked Parker with a love of shoes, she was approached constantly with propositions to start a mass-market, made-in-China shoe line. But she turned everyone down because she wanted to do things differently.“It felt, on principle, wrong,” said Parker. “My agents were like ‘What part of this is uninteresting to you?’”Parker said she had no money for marketing, no money for PR and no money to gift people things when she started her shoe business. But what she did have was the ability to sit down with women and help them figure out what they want.SJP Collection’s shoes are made in Italy and cost more than $300. It has two standalone stores in New York and has entered several international markets. In June, it launched an e-commerce business.Gathering Data Is Key to Value-Based Pricing in Drug Industry (2:05 p.m.)The future for Pfizer Inc. is focused on diseases like cancer and rare disease “where we believe we have the capability, both on the scientific and the commercial side, to create impact,” said Angela Hwang, president of the drugmaker’s biopharmaceuticals group.In the debate over rising drug costs in the U.S., some advocate systems that would link the price of a treatment to its outcome for the patient -- so-called value-based pricing. Moving toward paying for value is important, Hwang said, but it faces challenges, starting with data availability.“We haven’t collected that data, because that’s not how we pay for it today,” she said. “And maybe we should.”Pfizer is also looking at using technology in a variety of areas, including diagnosing rare disease. Last month Pfizer and Bristol-Myers Squibb Co. announced a partnership with Fitbit to focus on cardiovascular monitoring. Technology can be useful both in research and helping patients “live with their conditions in an easier way, to help them take their medicines in an easier way,” Hwang said.Bigger Is Better for CVS Health (1:45 p.m.)It’s been about a year since CVS Health Corp. completed its $68 billion acquisition of health insurer Aetna.The combined company has a larger and more influential reach, including to address social conditions that have an outsize influence on one’s health, CEO Larry Merlo said. That includes access to fresh foods, transportation and housing, as well as meeting people locally, where they are, he said. That’s an advantage CVS Health has over health insurers, he said.“We can engage consumers around their health. We can do that as part of their regular routines,” he said. “And when we do that, we know we’re going to reduce overall health care costs.”Companies With Best AI Win in the Logistics Industry (12:30 p.m.)XPO Logistics Inc. is using artificial intelligence and predictive analytics to cut e-commerce fulfillment times to less than half and has reduced how long it takes to put returned merchandise back into the supply chain to one day from five, Chief Executive Officer Brad Jacobs said. About a fifth of e-commerce goods are returned and XPO handles about 200 million returns a year for companies including Nike Inc.“The companies that have the best technology, the best AI are the ones who win in this space,” Jacobs said.Automation and technology are changing how warehouses operate. The company is partnering with Nestle to build a warehouse in Europe that’s about the size of 10 football fields and will handle 1 million pallets a year while employing only 30 people per shift, the CEO said. A decade ago is would have employed about 1,000, he said.Blackstone Group Inc. has bought about 1 billion square feet of warehouse space around the world in the last decade as e-commerce has driven demand, said Kathleen McCarthy, global co-head of real estate for the private equity first.“We see e-commerce as a really powerful driver in the change of how goods are delivered to the ultimate consumer -- whether that’s a human being or business,” McCarthy said. “We have just tried to follow that and lean into that trend as we see that shift happening.”The challenge is that customers want warehouse space in densely populated areas where consumers live.Spoiler Alert: Netflix and Disney Already Won the Streaming Wars (12:05 p.m.)Jonathan Nelson knows a thing or two about streaming. He’s the chief executive officer of Providence Equity Partners, which was an early investor in the streaming service Hulu. As media and tech giants launch new online video channels, Nelson said he already knows who will win the so-called streaming wars: Netflix Inc. and Walt Disney Co.As Netflix adds subscribers globally, it can afford more shows and movies, he said. “I can’t imagine them not being one of the winners,” Nelson said. Disney has “enormously valuable brands,” he said, adding that “I would put money on them, too.” Traditional media companies will struggle to compete because their new Silicon Valley rivals don’t need to turn a profit on their streaming services. “For Amazon, whatever they do in video could be considered a marketing experiment for Prime.”Nelson said the big “wild card” in the media landscape will be what happens to the NFL’s broadcast rights when contracts with media companies are up in a few years -- and whether a tech giant like Amazon.com Inc. is able to snatch those rights away. “If you’re trying to figure out where streaming is going, the key point to watch out for is what happens to the NFL rights,” he said. “Where it goes will be very interesting.”Take On Less Risk Than Normal, Oaktree Capital co-Founder Advises (11:30 a.m.)Howard Marks, the co-founder and chairman of Oaktree Capital Group LLC, said now is not a time for investors to be aggressive. They should take on less risk than normal given where trends in the credit market have gone.A large amount of capital has flowed into the alternative markets where participants are putting money into risky assets “because they think they have to,” Marks said. The biggest challenge investors face is deciding how to get a “decent return in a low return world” without taking an abnormal amount of risk.The Los Angeles-based investment giant has thrived most in times of economic stress. The firm is one of the largest distressed-debt investors in the world with about $20 billion committed to troubled issuers. Marks agreed in March to sell a 62% stake in Oaktree to Brookfield Asset Management Inc., but he’ll still run Oaktree’s operations.After over a decade of economic expansion,“you can’t say we’re at the beginning” of the cycle, Marks said. In a low interest-rate environment, investors are pursuing risk assets and alternative assets “aggressively,” he said. Marks doesn’t characterize this phase as a bubble, but rather “advanced stages” of the economic cycle.In the markets, ultra-low interest rates below zero have warped calculations. “It makes sense that companies have taken on more debt because it’s so cheap,” he said. Marks notes that the more debt a company has, the less likely it is to get through a period of economic difficulty. “But in the meantime you’ve seen a lot of levering up.”Malls are More Resilient Than People Think, Simon Property’s Chief Says (11:05 a.m.)The situation with Sears is “sad and tragic,” Simon Property Group CEO David Simon said, but his company’s properties will get a boost from being able to use the space.The company will get to use real estate from old Sears stores to diversify its malls, adding eateries and health and wellness offerings, Simon said. In the Boston area, Simon Property took a former Sears and leased the space to Life Time Fitness and brought in restaurants around it.About the American Dream Mall, the massive new retail and entertainment property across the river from Manhattan in New Jersey, Simon said his firm passed on a chance to buy the property back in 2007, when a former owner ran into financial trouble.In general, the mall business is more resilient than most people think, Simon said. Even thought consumers have changed, well-located malls that adapt to changing tastes have done well. The company’s biggest challenge for the year ahead is reclaiming under-performing real estate and using it to improve the mall-going experience.And the biggest complaint about malls from consumers? Parking, according to Simon.TPG Is Investing ‘Aggressively‘ in Subscription Businesses (9:40 a.m.)Jim Coulter, the billionaire co-founder of TPG, said the private equity firm is investing in subscriptions business that drive consumers’ purchases in everything from food to clothing -- despite his view that there will eventually be a backlash to the model.“We are investing in it very aggressively,” Coulter said.TPG has invested in music-streaming service Spotify Technology SA and makeup service Ipsy. While Coulter expects the sector’s growth will remain robust, he cautioned that there will be a pushback against subscriptions.“In a world where four out of every 10 Americans are challenged to come up with $400 for a medical emergency, 61% of people are paying massive amounts more per month for subscriptions than they expect,” he said.Facebook’s Sandberg Says Election is ‘Highest Priority’ (9:30 a.m.)Facebook COO Sheryl Sandberg reiterated the importance of the 2020 election in the U.S., calling it a “massive test” for the social networking giant.“This is the highest priority for the next year,” Sandberg said.She emphasized the importance of Facebook’s ad library to provide transparency on who is paying for what advertisements. “That’s basically the Honest Ads Act,” Sandberg said, adding that while she doesn’t think such a legislation will ever pass, “we built it anyway.”Facebook has been under pressure in the past weeks as Chief Executive Officer Mark Zuckerberg defended his company’s policy of not fact-checking ads from politicians, in contrast to Twitter Inc., which decided to ban all political ads from the site. CNN reported Thursday that Facebook is considering making some changes to how it handles political ads, including how they can be targeted, how they are labeled and providing more information about who is paying for the ads.At the summit, Sandberg addressed other concerns surrounding the company. Breaking up the social networking site, which owns Instagram and WhatsApp, would decrease the apps’s ability to deal with issues like privacy and election security, the executive said. She also drew a contrast between the “American values” of U.S. tech companies and government influence over emerging Chinese competitors. “What comes behind breaking up the U.S. tech companies is not another U.S. tech company,” she said, but a Chinese tech giant.Sandberg also reiterated Facebook’s commitment to diversity and the importance of mentorship to bring about gender equity in tech and other industries. Noting a study from her Lean In Foundation that showed a majority of men are afraid to meet alone with a women at work, Sandberg said: “Don’t harass us, basic. But don’t ignore us either.” If men feel they cannot have dinner alone with a woman they work with, they shouldn’t dine with a man either, she said.Tech’s Role in Unlocking Medical Treatment (7:30 a.m ET)For drug companies, making a new treatment can take a decade or more. As a result, the year ahead -- the focus of the summit -- “can seem like a very short time,” Pfizer Inc. Chief Development Officer Rod MacKenzie said in opening remarks. “But we’re acutely aware that, for many people living with disease, a year can literally be a lifetime.”Data and algorithms can improve patient care by incorporating considerations from their behavior and environment, like patients with respiratory issues getting a text alert about air quality issues, said Aimee Quirk, chief executive officer of innovationOchsner, a company focused on digital health, analytics and precision medicine out of Ochsner Health System in Louisiana.InnovationOchsner has done this work in conditions like hypertension and diabetes for about five years and seen both better outcomes and reductions in cost, according to Quirk.Technology can also make health care more accessible by allowing patients to get treated at home, said Jeff Burbank, chief technology officer of Fresenius Medical Care North America. Fresenius, for example, has been trying to prepare patients for hurricanes by making sure their equipment is ready and they have enough supply, he said.There are limits to what tech can do to help. When it comes to artificial intelligence technology, “we’re a bit worried it’s overhyped,” said Bobby Green, chief medical officer of Roche Holding AG’s Flatiron Health and a practicing oncologist. “If you do artificial intelligence on a biased data-set, you’re just going to perpetuate disparities. So we worry about that.”Read MoreSee details on The Year Ahead Summit here.For Bloomberg Businessweek’s The Year Ahead 2020 issue, click here.(An earlier version corrected Sandberg’s spelling in the first paragraph.)\--With assistance from Katherine Doherty, Sabrina Willmer, Kiley Roache, Patrick Clark, Gerry Smith, Cynthia Koons, Thomas Black, Kim Bhasin and Emma Court.To contact the reporters on this story: Kristen V. Brown in San Francisco at kbrown340@bloomberg.net;David Wainer in New York at dwainer3@bloomberg.net;Kristine Owram in New York at kowram@bloomberg.netTo contact the editors responsible for this story: Cécile Daurat at cdaurat@bloomberg.net, Timothy Annett, Bill FariesFor more articles like this, please visit us at bloomberg.com©2019 Bloomberg L.P.
